NEW YORK — Vugene, a Lithuanian multiomics data analysis firm, said on Monday that it has raised €1 million ($1.1 million) in a private financing round.

纽约——立陶宛多组学数据分析公司Vugene周一表示，已在一轮私人融资中筹集了100万欧元（110万美元）。

The round was led by Superhero Capital with participation from NGL Ventures, Coinvest Capital, and unnamed angel investors.

本轮融资由Superhero Capital领投，NGL Ventures、Coinvest Capital以及未具名的天使投资人参与。

Vugene was founded in 2021 to offer analysis and interpretation services for genomic, transcriptomic, epigenomic, proteomic, single-cell, and other types of biological data.

Vugene 成立于 2021 年，为基因组学、转录组学、表观基因组学、蛋白质组学、单细胞及其他类型的生物数据提供分析和解读服务。

'Vugene analysis integrates data from multiple omics experiments, providing a comprehensive characterization of biological systems,' Vugene Founder and Chief Technology Officer Juozas Gordevičius said in a statement. 'This enables our customers to discover therapeutic targets, understand disease mechanisms, and develop advanced, more personalized diagnostic solutions.'.

“Vugene分析整合了来自多种组学实验的数据，提供了对生物系统的全面表征，”Vugene创始人兼首席技术官Juozas Gordevičius在一份声明中表示。“这使我们的客户能够发现治疗靶点，理解疾病机制，并开发先进且更加个性化的诊断解决方案。”